NCT01959516 - Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

COPD

Interventions

DRUG

Glycopyrronium

Glycopyrronium capsule for inhalation once per day via SDDPI

DRUG

Tiotropium

Tiotropium capsule for inhalation once per day via HandiHaler® device

DRUG

Placebo to glycopyrronium

Placebo to glycopyrronium capsule for inhalation once per day via SDDPI

DRUG

Placebo to tiotropium

Placebo to tiotropium capsule for inhalation once per day via HandiHaler® device

Trial Locations (21)

10043

Novartis Investigative Site, Orbassano

10119

Novartis Investigative Site, Berlin

12099

Novartis Investigative Site, Berlin

12502

Novartis Investigative Site, Geesthacht

13156

Novartis Investigative Site, Berlin

14467

Novartis Investigative Site, Potsdam

20138

Novartis Investigative Site, Milan

27003

Novartis Investigative Site, Lugo

50009

Novartis Investigative Site, Zaragoza

50122

Novartis Investigative Site, Florence

65187

Novartis Investigative Site, Wiesbaden

06108

Novartis Investigative Site, Halle

04103

Novartis Investigative Site, Leipzig

04275

Novartis Investigative Site, Leipzig

08026

Novartis Investigative Site, Barcelona

CB7 5JD

Novartis Investigative Site, Cambridge

WD25 7NL

Novartis Investigative Site, Watford

FY3 7EN

Novartis Investigative Site, Blackpool

BD9 6RJ

Novartis Investigative Site, Bradford

CF5 4AD

Novartis Investigative Site, Cardiff

ML2 0DP

Novartis Investigative Site, Wishaw